rs140166160

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020458.4(TTC7A):​c.2170C>A​(p.Gln724Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,609,952 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q724Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0045 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 52 hom. )

Consequence

TTC7A
NM_020458.4 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.22

Publications

12 publications found
Variant links:
Genes affected
TTC7A (HGNC:19750): (tetratricopeptide repeat domain 7A) This gene encodes a protein containing tetratricopeptide repeats. Mutations in this gene disrupt intestinal development and can cause early onset inflammatory bowel disease and intestinal atresia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
STPG4 (HGNC:26850): (sperm-tail PG-rich repeat containing 4) Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in DNA demethylation of male pronucleus and positive regulation of DNA demethylation. Predicted to act upstream of or within C-5 methylation of cytosine. Predicted to be located in cytoplasm and nucleus. Predicted to be active in female pronucleus; germinal vesicle; and male pronucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004559338).
BP6
Variant 2-47060786-C-A is Benign according to our data. Variant chr2-47060786-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 528469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0045 (686/152336) while in subpopulation NFE AF = 0.00723 (492/68026). AF 95% confidence interval is 0.0067. There are 4 homozygotes in GnomAd4. There are 341 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC7ANM_020458.4 linkc.2170C>A p.Gln724Lys missense_variant Exon 19 of 20 ENST00000319190.11 NP_065191.2 Q9ULT0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC7AENST00000319190.11 linkc.2170C>A p.Gln724Lys missense_variant Exon 19 of 20 2 NM_020458.4 ENSP00000316699.5 Q9ULT0-1

Frequencies

GnomAD3 genomes
AF:
0.00451
AC:
686
AN:
152218
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00510
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00723
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00499
AC:
1246
AN:
249682
AF XY:
0.00549
show subpopulations
Gnomad AFR exome
AF:
0.00166
Gnomad AMR exome
AF:
0.00381
Gnomad ASJ exome
AF:
0.00152
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000836
Gnomad NFE exome
AF:
0.00733
Gnomad OTH exome
AF:
0.00459
GnomAD4 exome
AF:
0.00713
AC:
10396
AN:
1457616
Hom.:
52
Cov.:
31
AF XY:
0.00706
AC XY:
5111
AN XY:
724414
show subpopulations
African (AFR)
AF:
0.00117
AC:
39
AN:
33422
American (AMR)
AF:
0.00366
AC:
163
AN:
44566
Ashkenazi Jewish (ASJ)
AF:
0.00166
AC:
43
AN:
25908
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39608
South Asian (SAS)
AF:
0.00687
AC:
590
AN:
85872
European-Finnish (FIN)
AF:
0.000919
AC:
49
AN:
53312
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5754
European-Non Finnish (NFE)
AF:
0.00821
AC:
9109
AN:
1108978
Other (OTH)
AF:
0.00653
AC:
393
AN:
60196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
551
1101
1652
2202
2753
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00450
AC:
686
AN:
152336
Hom.:
4
Cov.:
32
AF XY:
0.00458
AC XY:
341
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00180
AC:
75
AN:
41578
American (AMR)
AF:
0.00510
AC:
78
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4828
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00723
AC:
492
AN:
68026
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00616
Hom.:
7
Bravo
AF:
0.00457
TwinsUK
AF:
0.0102
AC:
38
ALSPAC
AF:
0.00986
AC:
38
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00663
AC:
57
ExAC
AF:
0.00482
AC:
585
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00709
EpiControl
AF:
0.00706

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTC7A: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Multiple gastrointestinal atresias Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
22
DANN
Benign
0.93
DEOGEN2
Benign
0.069
.;T;.
Eigen
Benign
0.039
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.0046
T;T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
1.4
.;L;.
PhyloP100
1.2
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.15
Sift
Benign
0.20
T;T;T
Sift4G
Benign
0.61
T;T;T
Polyphen
0.12
B;B;.
Vest4
0.26
MVP
0.81
MPC
0.078
ClinPred
0.0082
T
GERP RS
5.8
Varity_R
0.11
gMVP
0.40
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140166160; hg19: chr2-47287925; COSMIC: COSV99766319; COSMIC: COSV99766319; API